Periostin: A matricellular protein involved in peritoneal injury during peritoneal dialysis

Peritoneal Dialysis International

Volumn 33, Issue 5, 2013, Pages 515-528

  Braun, Niko ^a,b   Sen, Kontheari ^c,d   Alscher, M Dominik ^a,b   Fritz, Peter ^a,b   Kimmel, Martin ^a,b   Morelle, Johann ^e   Goffin, Eric ^e   Jörres, Achim ^f   Wüthrich, Rudolf P ^c   Cohen, Clemens D ^c,d   Segerer, Stephan ^c,d  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b Institute of Digital Medicine   (Germany)

^c PSI   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Encapsulating peritoneal sclerosis; Matricellular protein; Periostin; Peritoneal fibrosis; Simple peritoneal fibrosis

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE LEVEL; DISEASE SEVERITY; FIBROBLAST; HERNIOPLASTY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PERITONEAL BIOPSY; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL FIBROBLAST; PERITONEAL FIBROSIS; PERITONEAL INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; UREMIA;

ENCAPSULATING PERITONEAL SCLEROSIS; MATRICELLULAR PROTEIN; PERIOSTIN; PERITONEAL FIBROSIS; SIMPLE PERITONEAL FIBROSIS;

BIOPSY; CELL ADHESION MOLECULES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84885722405     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2010.00259     Document Type: Article

References (42)

1. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23:530-41.
2. Alscher DM, Reimold F. New facts about encapsulating peritoneal sclerosis as a sequel of long-term peritoneal dialysis-what can we do? Minerva Urol Nefrol 2007; 59:269-79.
3. Augustine T, Brown PW, Davies SD, Summers AM, Wilkie ME. Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract 2009; 111:c149-54.
4. Honda K, Nitta K, Horita S, Tsukada M, Itabashi M, Nihei H, et al. Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2003; 19:169-75.
5. Alscher DM, Braun N, Biegger D, Fritz P. Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients. Am J Kidney Dis 2007; 49:452-61.
6. Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblastspecific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 1993; 294:271-8.
7. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999; 14:1239-49.
8. 5 integrins and promotes cell motility. Cancer Res 2002; 62:5358-64.
9. Norris RA, Moreno-Rodriguez R, Hoffman S, Markwald RR. The many facets of the matricellular protein periostin during cardiac development, remodeling, and pathophysiology. J Cell Commun Signal 2009; 3:275-86.
10. Zhu M, Fejzo MS, Anderson L, Dering J, Ginther C, Ramos L, et al. Periostin promotes ovarian cancer angiogenesis and metastasis. Gynecol Oncol 2010; 119:337-44.
11. Sidhu SS, Yuan S, Innes AL, Kerr S, Woodruff PG, Hou L, et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A 2010; 107:14170-5.
12. Kii I, Amizuka N, Minqi L, Kitajima S, Saga Y, Kudo A. Periostin is an extracellular matrix protein required for eruption of incisors in mice. Biochem Biophys Res Commun 2006; 342:766-72.
13. Norris RA, Kern CB, Wessels A, Moralez EI, Markwald RR, Mjaatvedt CH. Identification and detection of the periostin gene in cardiac development. Anat Rec A Discov Mol Cell Evol Biol 2004; 281:1227-33.
14. Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 2001; 103:183-8.
15. Rios H, Koushik SV, Wang H, Wang J, Zhou HM, Lindsley A, et al. Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol 2005; 25:11131-44.
16. Asakura M, Kitakaze M. Global gene expression profiling in the failing myocardium. Circ J 2009; 73:1568-76.
17. Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 2010; 48:504-11.
18. Ruan K, Bao S, Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 2009; 66:2219-30.
19. Lindenmeyer MT, Eichinger F, Sen K, Anders HJ, Edenhofer I, Mattinzoli D, et al. Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset. PLoS One 2010; 5:e11545.
20. Sen K, Lindenmeyer MT, Gaspert A, Eichinger F, Neusser MA, Kretzler M, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol 2011; 179:1756-67.
21. Pohjolainen V, Rysa J, Napankangas J, Koobi P, Eraranta A, Ilves M, et al. Left ventricular periostin gene expression is associated with fibrogenesis in experimental renal insufficiency. Nephrol Dial Transplant 2012; 27:115-22.
22. Satirapoj B, Wang Y, Chamberlin MP, Dai T, LaPage J, Phillips L, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant 2012; 27:2702-11.
23. Zou P, Wu LL, Wu D, Fan D, Cui XB, Zhou Y, et al. High glucose increases periostin expression and the related signal pathway in adult rat cardiac fibroblasts [Chinese]. Sheng Li Xue Bao 2010; 62:247-54.
24. Bolton K, Segal D, McMillan J, Sanigorski A, Collier G, Walder K. Identification of secreted proteins associated with obesity and type 2 diabetes in Psammomys obesus. Int J Obes (Lond) 2009; 33:1153-65.
25. Günal AI, Duman S, Sen S, Unsal A, Terzioǧlu E, Akçiçek F, et al. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution. J Nephrol 2001; 14:184-9.
26. Ha H, Lee HB. Effect of high glucose on peritoneal mesothelial cell biology. Perit Dial Int 2000; 20(SUPPL 2):S15-18.
27. Schilte MN, Celie JW, Wee PM, Beelen RH, van den Born J. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis. Perit Dial Int 2009; 29:605-17.
28. Braun N, Alscher DM, Fritz P, Edenhofer I, Kimmel M, Gaspert A, et al. Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2011; 26:1033-41.
29. Neusser MA, Kraus AK, Regele H, Cohen CD, Fehr T, Kerjaschki D, et al. The chemokine receptor cxcr7 is expressed on lymphatic endothelial cells during renal allograft rejection. Kidney Int 2010; 77:801-8.
30. Jedlicka J, Soleiman A, Draganovici D, Mandelbaum J, Ziegler U, Regele H, et al. Interstitial inflammation in Alport syndrome. Hum Pathol 2010; 41:582-93.
31. Witowski J, Jörres A. Peritoneal cell culture: fibroblasts. Perit Dial Int 2006; 26:292-9.
32. Cohen CD, Frach K, Schlondorff D, Kretzler M. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 2002; 61:133-40.
33. Ben QW, Zhao Z, Ge SF, Zhou J, Yuan F, Yuan YZ. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer. Int J Oncol 2009; 34:821-8.
34. Hakuno D, Kimura N, Yoshioka M, Mukai M, Kimura T, Okada Y, et al. Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest 2010; 120:2292-306.
35. Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis-a multicentre study in Japan. Nephrol Dial Transplant 2007; 22:560-7.
36. Kurata K, Maruyama S, Kato S, Sato W, Yamamoto J, Ozaki T, et al. Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice. Am J Physiol Renal Physiol 2009; 297:F1510-17.
37. Yamamoto D, Takai S, Hirahara I, Kusano E. Captopril directly inhibits matrix metalloproteinase-2 activity in continuous ambulatory peritoneal dialysis therapy. Clin Chim Acta 2010; 411:762-4.
38. Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol 2010; 21:1077-85.
39. Braun N, Reimold F, Biegger D, Fritz P, Kimmel M, Ulmer C, et al. Fibrogenic growth factors in encapsulating peritoneal sclerosis. Nephron Clin Pract 2009; 113:c88-95.
40. Shao R, Bao S, Bai X, Blanchette C, Anderson RM, Dang T, et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up- regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 2004; 24:3992-4003.
41. Kim YL. Update on mechanisms of ultrafiltration failure. Perit Dial Int 2009; 29(Suppl 2):S123-7.
42. Sherif AM, Yoshida H, Maruyama Y, Yamamoto H, Yokoyama K, Hosoya T, et al. Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis. Ther Apher Dial 2008; 12:33-41.